Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) 4 Chloro 3 Hydroxy Butyrate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111172124B details a YOL151W mutant for high-concentration synthesis, offering cost-effective pharma intermediate manufacturing.
Patent CN114908129B reveals a novel dehydrogenase mutant for high-purity (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering significant cost and supply chain advantages.
Patent CN102952028A details a high-yield L-carnitine synthesis using Ru-catalysis. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN111172124A reveals a novel carbonyl reductase mutant enabling high-concentration synthesis. Discover cost-effective supply chain solutions for this key pharma intermediate.
Patent CN113652408B reveals mutant enzyme for high-purity intermediate. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.